Insurance Benefit Evaluation Committee assesses benefit for ‘Rupapin Tab’ and conditional uninsured for ‘Edarbi Tab’
The Health Insurance Review & Assessment Service Health Insurance Benefit Evaluation Committee held a meeting on the 27th and assessed propriety for health insurance benefits on 10 companies’ 15 products.
According to the decision result, Takeda Korea’s Edarbi Tab(20, 40 & 80mg), an essential hy...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
